Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ventyx Biosciences, Inc.

2.46
+0.21009.33%
Post-market: 2.40-0.0600-2.44%19:37 EDT
Volume:3.52M
Turnover:8.33M
Market Cap:175.06M
PE:-1.40
High:2.47
Open:2.23
Low:2.23
Close:2.25
Loading ...
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2025

Major Issues Report

Form 8-K - Current report
Feb 28, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Major Issues Report

Form 8-K - Current report
Dec 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Correspondence

Form CORRESP - Correspondence
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report
Sep 23, 2024

Major Issues Report

Form 8-K - Current report
Aug 30, 2024

Major Issues Report

Form 8-K - Current report
Aug 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2024

Major Issues Report

Form 8-K - Current report
Jun 26, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 06, 2024

Major Issues Report

Form 8-K - Current report